Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ · Healthcare
Eloxx Pharmaceuticals, Inc. Total Liabilities 2010–2025
Eloxx Pharmaceuticals, Inc. annual total liabilities history from 2012 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Eloxx Pharmaceuticals, Inc. total liabilities as of December 31, 2025: 17.2M, a 37.11% decrease year-over-year.
- Eloxx Pharmaceuticals, Inc. total liabilities for 2025 were 17.2M, a 37.11% decrease from 2024.
- Eloxx Pharmaceuticals, Inc. total liabilities for 2024 were 27.3M, a 12.34% increase from 2023.
- Eloxx Pharmaceuticals, Inc. total liabilities for 2023 were 24.3M, a 315.94% increase from 2014.
- Eloxx Pharmaceuticals, Inc. total liabilities for 2014 were 5.8M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Eloxx Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $17 |
| 2024 | $27 |
| 2023 | $24 |
| 2014 | $6 |
| 2013 | $3 |
| 2012 | $4 |
Eloxx Pharmaceuticals, Inc. Total Liabilities — FAQ
Eloxx Pharmaceuticals, Inc. (ELOX) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ELOX's total liabilities history?
The chart and table above show Eloxx Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.